Fountain TRT Appears in 15.7% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- Fountain TRT appears in 57 of 363 benchmark answers, with 25 recommendations and only one first-place placement.
- Most recorded mentions are neutral or positive, so the main issue is position in answers rather than sentiment.
- One medium-priority claim conflict was found, centered on Trustpilot rating and review count.
- The plan focuses on verifying facts, reviewing cited third-party pages, and building content around common buyer questions.
Answer Capsule
In November 2026, Fountain TRT appeared in 57 of 363 AI answers included in the TRT Clinics benchmark (15.70%). It received 25 recommendations (6.89%), with 13 Top 3 placements and 1 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do Fountain TRT mentions, recommendations and placements compare with its TRT Clinics peers?
Fountain TRT recorded 57 mentions (15.70%) and 25 recommendations (6.89%) across 363 answers included in the benchmark. Top 3 placements numbered 13; first-place recommendations numbered 1. Framing among its mentions was 26 positive, 31 neutral and 0 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Hone Health | 271 | 74.66% | 146 | 40.22% | 123 | 33.88% | 64 | 17.63% |
2 | Defy Medical | 113 | 31.13% | 81 | 22.31% | 64 | 17.63% | 12 | 3.31% |
3 | Maximus | 116 | 31.96% | 64 | 17.63% | 49 | 13.50% | 18 | 4.96% |
4 | Marek Health | 78 | 21.49% | 39 | 10.74% | 30 | 8.26% | 7 | 1.93% |
5 | Henry Meds | 86 | 23.69% | 35 | 9.64% | 28 | 7.71% | 6 | 1.65% |
6 | Fountain TRT | 57 | 15.70% | 25 | 6.89% | 13 | 3.58% | 1 | 0.28% |
7 | Renew Vitality | 6 | 1.65% | 5 | 1.38% | 5 | 1.38% | 0 | 0.00% |
8 | Low T Center | 11 | 3.03% | 4 | 1.10% | 2 | 0.55% | 1 | 0.28% |
9 | BioTE | 7 | 1.93% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
9 | Craft Concierge | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
Fountain TRT appears in a meaningful share of the benchmark answers, and most of those appearances also carry a recommendation. That is real reach. The gap sits in position: it is named far more often than it is placed at the front of an answer, so the practical question is how to move from being one option among several to being the one named first.
Framing is not the weak point. Almost none of the recorded wording about the company was negative, and a large block was neutral. Neutral mentions are an opening rather than a problem: they show the company is present in answers without a strong reason to prefer it. The agency would treat position, not sentiment, as the visibility priority.
What changed since last month
Questions This Section Answers
- How did Fountain TRT counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 57 / 363 (15.70%) |
Recommendations | 25 / 363 (6.89%) |
Top 3 recommendations | 13 / 363 (3.58%) |
#1 recommendations | 1 / 363 (0.28%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first broad baseline, so the monthly figures describe one selected sample rather than a trend. Earlier editions asked a narrower set of questions, which makes their numbers a different measurement rather than an earlier point on the same line. Nothing here should be read as growth or decline.
The useful consequence is that this month becomes the reference point. Future editions screened the same way can be compared against it, and only then will movement mean something. Until that comparison exists, the agency would avoid drawing conclusions from a single month and would set expectations around the baseline itself.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- Fountain TRTno changeNov 20266.89%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for Fountain TRT?
AI answers contained 1 conflicting claim about Fountain TRT: 0 critical, 0 high, 1 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
The fact-checking list is short: one disputed claim, rated medium, with nothing critical or high. That is a manageable starting point rather than an emergency. The rating orders the work; it does not establish that the company or any publisher got something wrong, so the claim stays open until someone checks it against a current primary source.
The agency would pair this with a visibility comparison that shows where Fountain TRT sits against the clinics named more often and more prominently. Together, the claim list and the comparison let the client decide what to fix first and what to leave alone.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about Fountain TRT should be verified before proposed page edits?
Review topic | Severity | Recorded AI claim A | Recorded AI claim B |
|---|---|---|---|
Trustpilot rating and review count | medium | 4.8/5 across 1,200+ reviews | about 4.4/5 from 397 reviews |
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
The disputed topic is the company's Trustpilot rating and review count, where two recorded answers give different figures. Both are quotations from AI answers, not verified facts, and a difference in dates or in which profile was read could account for the gap. The first step is to confirm the entity and the current rating on the platform itself.
Only after that check would the agency propose a page brief, and only if the company's own pages are the right place to settle the point. If the verified figure matches one answer, the brief states it plainly; if the conflict sits elsewhere, no page change is proposed.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for Fountain TRT?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://telehealthally.com/reviews/fountain-trt-review | 2 | 2 | 1 |
https://alphahealthfinder.com/online-providers/trt-testosterone/fountain-trt | 1 | 1 | 1 |
https://doseworth.com/reviews/fountain-trt | 1 | 1 | 1 |
https://pparx.org/testosterone/fountain-trt-review/ | 1 | 1 | 1 |
https://telehealthmatch.com/brand/fountain-trt | 1 | 1 | 1 |
https://trtauthority.com/telehealth/fountain-trt/ | 1 | 1 | 1 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
Several third-party review pages were cited alongside answers that mention Fountain TRT, and one of them is linked to the disputed rating claim. A citation is not proof that a page shaped the answer, and a page linked to a conflicting claim is not necessarily its cause. Each page needs to be read as it stands today before anything is requested.
The agency would review the selected pages, note which figures they currently publish, and prepare evidence-backed requests only where a page is out of date and the company can supply a verifiable correction. Pages that are accurate or simply opinion stay untouched.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed Fountain TRT website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://fountaintrt.com/ | 2 | 2 | 1 |
https://news.fountaintrt.com/c6096f56-1bde-11ec-8ae5-0242fb20989c-254/ | 1 | 1 | 0 |
https://news.fountaintrt.com/referred/ | 1 | 1 | 0 |
The company's website was cited 4 times across 3 distinct page addresses; the table shows 3 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The company's own site was cited a handful of times, mostly through the homepage, with the news pages appearing without accompanying recommendations. That pattern suggests the main site is doing the citing work while other owned pages are being picked up incidentally. It is a small sample, so the agency would treat it as a prompt to look rather than a verdict.
Page briefs would be built from approved company facts and the questions buyers actually ask, then checked against what each page already covers. Where coverage exists, the brief improves it; where it does not, a new page is proposed.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for Fountain TRT?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What's the best online TRT clinic? | 3 | 2 | 2 |
What is the alternative to Ways2Well? | 4 | 1 | 1 |
What is the best online TRT clinic? | 5 | 1 | 1 |
What is the best online TRT? | 4 | 1 | 1 |
What is the best online testosterone replacement therapy? | 2 | 1 | 1 |
Where can I get a prescription for testosterone online? | 2 | 1 | 1 |
Where is the best place to buy testosterone online? | 2 | 1 | 1 |
Where is the best place to get TRT online? | 4 | 1 | 1 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The recorded questions cluster around choosing an online TRT clinic and finding a legitimate prescription source, with a smaller thread asking what to use instead of a named competitor. Fountain TRT was mentioned in most of these and recommended in nearly all of those mentions, which suggests the company already answers the buyer's question reasonably well when it appears.
The opportunity is coverage rather than repair. The agency would check whether existing pages address each question directly, then draft briefs for the gaps, using the buyer's own wording and the company's approved clinical and commercial facts.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed Fountain TRT work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline: a scorecard, a scoped fact-review register and a shortlist of pages and sources, each with an owner and a stated evidence requirement. Nothing is corrected in this period; the work is to know what exists and what needs checking.
The second month turns confirmed findings into page briefs and justified publisher requests, with confirmed edits, no-change decisions and outstanding requests recorded separately. The third month adds buyer-question content briefs and a fresh scorecard. Completed work is reported as work done, kept apart from any movement in the answers themselves.
Methodology
Questions This Section Answers
- How are Fountain TRT answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 363 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 800 captured answers and 5316 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 363 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The answers behind these figures were collected for this reporting month, though the exact collection dates are unverified. A company counts as recommended only when an answer endorses it with positive wording, and the placement counts sit inside those recommendations rather than adding to them. Answers can name several companies, so counts do not sum to a number of distinct answers.
Sentiment describes answer wording, not customer satisfaction. The citation analysis covers a wider set of captured answers than the benchmark, and cited pages still need independent checking. This edition sets a broader baseline; earlier editions used narrower questions and are not treated as a trend.
Our first three priorities
First, verify the disputed Trustpilot figure against the platform itself and decide whether any owned page needs to state it. This is the only open claim, and settling it removes the one point where the company's story is inconsistent across answers.
Second, review the third-party pages already cited alongside the company and prepare correction requests only where a page is demonstrably out of date. Third, build buyer-question briefs around clinic choice and online prescriptions, checking existing coverage first. Position in answers, not sentiment, is the visibility goal these three support.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


